Drugs / KL002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05882487 | Jun 2023 → Apr 2026 | Parkinson disease | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KL002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05882487 ↗ |
| Route | Other | “bilateral intraputaminal injections of KL002 through stereotactic brain surgery” NCT05882487 ↗ |